Escalon(R) Reports Third Quarter Fiscal 20...(the operations of the Company's b...)

operations of the Company's business units, including the integration

of Drew's and MRP's operations, the reorganization of the Drew

business and the integration of any acquisitions it may undertake, if

any, of which there can be no assurance,

-- implement cost reductions,

-- generate cash,

-- identify, finance and enter into business relationships and

acquisitions.

Other factors include uncertainties and risks related to:

-- new product development, commercialization, manufacturing and market

acceptance of new products,

-- marketing acceptance of existing products in new markets,

-- research and development activities, including failure to demonstrate

clinical efficacy,

-- delays by regulatory authorities, scientific and technical advances by

Escalon or third parties,

-- introduction of competitive products,

-- third party reimbursement and physician training, and

-- general economic conditions.

Further information about these and other relevant risks and uncertainties may be found in the Company's report on Form 10- K for year ended June 30, 2007 and on Form 10Q forth quarter ended March 31, 2008, and its other filings with the Securities and Exchange Commission, all of which are available from the Securities and Exchange Commission as well as other sources.

ESCALON MEDICAL CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

Three Months Ended Nine Months Ended

March 31, March 31,

2008 2007 2008 2007

Net revenues:

Product revenue $8,138,627 $6,900,461 $22,421,603 $20,477,907

Other revenue 48
'/>"/>